|
市場調査レポート
商品コード
1547530
イソキサゾリンの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測Global Isoxazoline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
||||||
カスタマイズ可能
|
|||||||
| イソキサゾリンの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測 |
|
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
イソキサゾリン市場の世界需要は、2023年の16億米ドルから2032年には約54億5,000万米ドルの市場規模に達すると推定され、調査期間2024～2032年のCAGRは14.55%です。
イソオキサゾリンは、互いに隣接する酸素と窒素の各1原子からなる5員複素環化合物の一種です。ニトリルオキシドとアルケンの1,3-双極性付加環化反応、N-メチル化による2-イソオキサゾリン、ニトロンとアルキンの付加環化反応によって製造できます。イソオキサゾリン類には様々な用途があり、その多くは生物学的に活性です。イソオキサゾリン類は幅広い殺虫・殺ダニ活性を示し、ノミやダニなど多くの動物寄生虫に有効です。
市場力学
世界のイソキサゾリン市場は予測期間中、安定した成長率を示すと予測されます。ペットへの寄生虫攻撃の増加、イソキサゾリンの可能性に関する調査の進展、ペット飼育率の上昇が、世界のイソキサゾリン市場を舵取りする要因となっています。イソキサゾリンは、殺虫、抗菌、抗生物質、抗腫瘍、抗真菌、抗結核、抗がん、潰瘍原性などの特性を持つため、医薬品や治療での使用や探索が拡大しています。また、イソキサゾリンは抗がん剤として医薬化学のセグメントで大きな意義を得ています。しかし、イソキサゾリンが犬や猫に神経系の有害事象を引き起こす可能性があるとしてFDAから警告を受けた例は少なく、市場の成長を抑制しています。
この調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、イソキサゾリンの世界市場における各セグメントを包括的に評価することもできます。イソキサゾリン産業の成長と動向は、この調査に全体的なアプローチを記載しています。
市場セグメンテーション
イソキサゾリン市場レポートのこのセクションでは、国別と地域別のセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスの対象層を特定する上で、今後の機会を支援します。
地域分析
このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるイソキサゾリン市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。
カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。
目次
第1章 序文
第2章 エグゼクティブサマリー
- 市場のハイライト
- 世界市場スナップショット
第3章 イソキサゾリン-産業分析
- イントロダクション：市場力学
- 市場促進要因
- 市場抑制要因
- 市場機会
- 業界動向
- ポーターのファイブフォース分析
- 市場の魅力分析
第4章 バリューチェーン分析
- バリューチェーン分析
- 原材料分析
- 原材料リスト
- 原材料メーカー一覧
- 主要原材料の価格動向
- 潜在的バイヤー一覧
- マーケティングチャネル
- 直接マーケティング
- 間接マーケティング
- マーケティングチャネル発展動向
第5章 イソキサゾリンの世界市場分析：製品タイプ別
- 製品タイプ別概要
- 製品タイプ別過去・予測データ分析
- フルララナー
- アフォキソラナー
- サロラナー
- ロチラナー
第6章 イソキサゾリンの世界市場分析：ペットタイプ別
- ペットタイプ別概要
- ペットタイプ別過去・予測データ分析
- 猫
- 犬
第7章 イソキサゾリンの世界市場分析：地域別
- 地域別展望
- イントロダクション
- 北米の売上分析
- 概要、実績と予測
- 北米：セグメント別
- 北米：国別
- 米国
- カナダ
- メキシコ
- 欧州売上分析
- 概要、実績と予測
- 欧州：セグメント別
- 欧州：国別
- 英国
- フランス
- ドイツ
- イタリア
- ロシア
- その他の欧州
- アジア太平洋売上分析
- 概要、実績と予測
- アジア太平洋：セグメント別
- アジア太平洋：国別
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- 東南アジア
- その他のアジア太平洋
- ラテンアメリカ売上分析
- 概要、実績と予測
- ラテンアメリカ：セグメント別
- ラテンアメリカ：国別
- ブラジル
- アルゼンチン
- ペルー
- チリ
- その他のラテンアメリカ
- 中東・アフリカ売上分析
- 概要、実績と予測
- 中東・アフリカ：セグメント別
- 中東・アフリカ：国別一覧
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他の中東・アフリカ
第8章 イソキサゾリン企業の競合情勢
- イソキサゾリン市場競合
- 提携・協力・契約
- 合併・買収
- 新製品の上市
- その他の開発
第9章 企業プロファイル
- 上位企業の市場シェア分析
- 市場集中度
- Merck Animal Health Inc
- Elanco Animal Health Incorporated
- Boehringer Ingelheim International GmbH
- Zoetis Inc. Etc
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Product Type (Thousand Units and USD MN)
- Fluralaner Market Sales By Geography (Thousand Units and USD MN)
- Afoxolaner Market Sales By Geography (Thousand Units and USD MN)
- Sarolaner Market Sales By Geography (Thousand Units and USD MN)
- Lotilaner Market Sales By Geography (Thousand Units and USD MN)
- Analysis By Pet Type (Thousand Units and USD MN)
- Cat Market Sales By Geography (Thousand Units and USD MN)
- Dog Market Sales By Geography (Thousand Units and USD MN)
- Global Isoxazoline Market Sales By Geography (Thousand Units and USD MN)
- North America Market Analysis (Thousand Units and USD MN)
- United States Market Analysis (Thousand Units and USD MN)
- Canada Market Analysis (Thousand Units and USD MN)
- Mexico Market Analysis (Thousand Units and USD MN)
- Europe Market Analysis (Thousand Units and USD MN)
- Europe Market Estimate By Country (Thousand Units and USD MN)
- United Kingdom Market Analysis (Thousand Units and USD MN)
- France Market Analysis (Thousand Units and USD MN)
- Germany Market Analysis (Thousand Units and USD MN)
- Italy Market Analysis (Thousand Units and USD MN)
- Russia Market Analysis (Thousand Units and USD MN)
- Spain Market Analysis (Thousand Units and USD MN)
- Rest of Europe Market Analysis (Thousand Units and USD MN)
- Asia Pacific Market Analysis (Thousand Units and USD MN)
- China Market Analysis (Thousand Units and USD MN)
- Japan Market Analysis (Thousand Units and USD MN)
- India Market Analysis (Thousand Units and USD MN)
- South Korea Market Analysis (Thousand Units and USD MN)
- Australia Market Analysis (Thousand Units and USD MN)
- South East Asia Market Analysis (Thousand Units and USD MN)
- Rest of Asia Pacific Market Analysis (Thousand Units and USD MN)
- Latin America Market Analysis (Thousand Units and USD MN)
- Brazil Market Analysis (Thousand Units and USD MN)
- Argentina Market Analysis (Thousand Units and USD MN)
- Peru Market Analysis (Thousand Units and USD MN)
- Chile Market Analysis (Thousand Units and USD MN)
- Rest of Latin America Market Analysis (Thousand Units and USD MN)
- Middle East & Africa Market Analysis (Thousand Units and USD MN)
- Saudi Arabia Market Analysis (Thousand Units and USD MN)
- UAE Market Analysis (Thousand Units and USD MN)
- Israel Market Analysis (Thousand Units and USD MN)
- South Africa Market Analysis (Thousand Units and USD MN)
- Rest of Middle East and Africa Market Analysis (Thousand Units and USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Isoxazoline Report
- Market Research Process
- Market Research Methodology
- Global Isoxazoline Market Size, By Region (Thousand Units and USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Product Type
- Market Attractiveness Analysis By Pet Type
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Product Type (Thousand Units and USD MN)
- Fluralaner Market Sales By Geography (Thousand Units and USD MN)
- Afoxolaner Market Sales By Geography (Thousand Units and USD MN)
- Sarolaner Market Sales By Geography (Thousand Units and USD MN)
- Lotilaner Market Sales By Geography (Thousand Units and USD MN)
- Global Market Analysis By Pet Type (Thousand Units and USD MN)
- Cat Market Sales By Geography (Thousand Units and USD MN)
- Dog Market Sales By Geography (Thousand Units and USD MN)
- Global Market Sales (Thousand Units and USD MN)
- North America Market Sales (Thousand Units and USD MN)
- Europe Market Sales (Thousand Units and USD MN)
- Asia Pacific Market Sales (Thousand Units and USD MN)
- Latin America Market Sales (Thousand Units and USD MN)
- Middle East & Africa Market Sales (Thousand Units and USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
The global demand for Isoxazoline Market is presumed to reach the market size of nearly USD 5.45 Billion by 2032 from USD 1.6 Billion in 2023 with a CAGR of 14.55% under the study period 2024-2032.
Isoxazoline is a class of five-membered heterocyclic compounds, comprising one atom each of oxygen and nitrogen, located adjacent to each other. It can be produced by the 1,3-dipolar cycloaddition of nitrile oxides with alkenes, 2-isoxazolines by N-methylation, and cycloaddition between a nitrone and an alkyne. Isoxazolines have a variety of uses, with many being biologically active. They exhibit a broad spectrum of insecticidal and acaricidal activity and are effective against many veterinary parasites such as fleas and ticks.
MARKET DYNAMICS
The global isoxazoline market is estimated to grow at a steady rate during the forecast period. Increasing parasite attacks on pets, advancing research on the potentials of isoxazoline, and rising pet ownership are factors steering the global isoxazoline market. Isoxazoline is finding its expanding use and exploration in pharmaceuticals and therapeutics due to the properties such as insecticidal, antibacterial, antibiotic, antitumor, antifungal, antituberculosis, anticancer, and ulcerogenic. In addition, Isoxazoline has gained much significance in the field of medicinal chemistry as an anticancer agent. However, few alerts were received from the FDA about isoxazoline's potential for neurologic adverse events in dogs and cats, restraining market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Isoxazoline. The growth and trends of Isoxazoline industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Isoxazoline market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Fluralaner
- Afoxolaner
- Sarolaner
- Lotilaner
By Pet Type
- Cat
- Dog
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Isoxazoline market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Isoxazoline market include Merck Animal Health Inc, Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Zoetis Inc. Etc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. ISOXAZOLINE - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Pet Type
- 3.7.3 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL ISOXAZOLINE MARKET ANALYSIS BY PRODUCT TYPE
- 5.1. Overview By Product Type
- 5.2. Historical and Forecast Data Analysis By Product Type
- 5.3. Fluralaner Historic and Forecast Sales By Regions
- 5.4. Afoxolaner Historic and Forecast Sales By Regions
- 5.5. Sarolaner Historic and Forecast Sales By Regions
- 5.6. Lotilaner Historic and Forecast Sales By Regions
6. GLOBAL ISOXAZOLINE MARKET ANALYSIS BY PET TYPE
- 6.1. Overview By Pet Type
- 6.2. Historical and Forecast Data Analysis By Pet Type
- 6.3. Cat Historic and Forecast Sales By Regions
- 6.4. Dog Historic and Forecast Sales By Regions
7. GLOBAL ISOXAZOLINE MARKET ANALYSIS BY GEOGRAPHY
- 7.1. Regional Outlook
- 7.2. Introduction
- 7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
- 7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
- 7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
- 7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
- 7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis
8. COMPETITIVE LANDSCAPE OF THE ISOXAZOLINE COMPANIES
- 8.1. Isoxazoline Market Competition
- 8.2. Partnership/Collaboration/Agreement
- 8.3. Merger And Acquisitions
- 8.4. New Product Launch
- 8.5. Other Developments
9. COMPANY PROFILES OF ISOXAZOLINE INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Market Concentration Rate
- 9.3. Merck Animal Health Inc
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
- 9.4. Elanco Animal Health Incorporated
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
- 9.5. Boehringer Ingelheim International GmbH
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
- 9.6. Zoetis Inc. Etc
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
